
Article • Between good practice and financial pitfalls
Delivering molecular pathology at lower costs
Molecular pathology should become centralised in fewer labs to improve efficiencies and affordability, according to leading European experts.

Molecular pathology should become centralised in fewer labs to improve efficiencies and affordability, according to leading European experts.

The pace of artificial intelligence (AI) adoption in personalised medicine is unsettling for great parts of the public. A new survey reflects the worried state of mind in the UK.

Staff shortage, financial burdens, and growing demand for care are major challenges for healthcare institutions. The latest Future Health Index report indicates that AI is seen as a key solution.

Lung cancer screenings save lives – especially for those who live in economically deprived areas, a new study confirms. The researchers further demonstrate the benefits of using low-dose CT imaging.

Heat islands found in many European cities have a clear impact on human mortality risk, comparable to air pollution. A new study has produced the first cost estimate of this impact.

While genetic information may lead to better treatments, promises of cost savings are unfounded. Instead, a large additional bill is more likely, according to University of Copenhagen researchers.

The world's leading medical trade fair MEDICA 2023 starts on Monday in Düsseldorf with more than 5,300 exhibiting companies from almost 70 nations and the kick-off event for the accompanying 46th German Hospital Day, which will be attended by Federal Health Minister Karl Lauterbach (via video link) and NRW Health Minister Karl-Josef Laumann. COMPAMED 2023 will take place parallel to MEDICA. As…

The Wallonia Export & Investment Agency welcomes the entire spectrum of the MedTech Industry on the Belgium Pavilion at Medica 2023 (Nov 13-16).

MEDICA trade fair (Nov 13-16, Düsseldorf) is a major event for start-ups entering the health sector. Hundreds of young developers seek business contacts for cooperation concerning funding, production, approval, marketing or sales of their products.

Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at the European Society of Cardiology's ESC Congress 2023.

A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs.

Under the impulse of the European Commission, the in vitro diagnostic industry is developing emerging technologies to implement sustainable practices in medical laboratories. As sustainability has been a growing priority of the European Union (EU) in the last decade, ‘the medical technology sector, particularly the IVD sector, must comply with European legislation in this field like all other…

Medical Taiwan 2023 (June 8-10) features a total of 250 exhibitors presenting their expertise in the fields of ‘Digital Leap,’ ‘Supply Chain,’ ‘Innovation Force,’ ‘People-centric Future,’ and ‘All Age Healthcare.’

Medical Taiwan is set to bring together leading manufacturers, suppliers, importers and experts from around the world to showcase the latest innovations, technologies, and products in the field.

A new study calculated the economic cost of cancers around the world, helping policymakers allocate resources and enact policies to curb the increase in cancer-related death and disability.

Bayer announced the acquisition of Blackford Analysis Ltd., a global strategic imaging platform and solutions provider for artificial intelligence (AI) in radiology.

Current EU regulation does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from Finland concludes.

A company’s impact on society, economy and the environment cannot be measured in financial terms alone – and hospitals are no exception. On the contrary: the idea of measuring the quality of healthcare only in economic terms has always been fraught with problems. Hospitals as organizations have always played an important social role, and their environmental impact is increasingly recognized.

Outsourcing NHS services to the private sector is associated with reduced quality of patient care and increased rates of deaths from treatable causes.